Aquestive Therapeutics, Inc. AQST Interest income and other income, net
Interest income and other income, net at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept aqst:InterestAndOtherIncomeNet.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s interest income and other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s interest income and other income, net?
- Aquestive Therapeutics, Inc. (AQST) reported interest income and other income, net of $83K in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s interest income and other income, net changed year-over-year?
- Aquestive Therapeutics, Inc.'s interest income and other income, net decreased by 88.4% year-over-year, from $713K to $83K.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s interest income and other income, net?
- Over 3 years (2022 to 2025), Aquestive Therapeutics, Inc.'s interest income and other income, net has grown at a 253.3% compound annual growth rate (CAGR), from $99K to $4.37M.
- What does interest income and other income, net mean?
- This metric aggregates non-operating financial inflows, including interest earned on cash balances, investment income, and other miscellaneous gains or losses not related to core business operations. It provides a view of the company's ability to generate supplemental returns from its treasury activities and non-core assets. A positive balance can help offset operating losses, while volatility here may indicate changes in cash management strategies.